DCDaniel Alexander Changestu

Daniel Alexander Changestu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daniel Alexander Changestu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach

    by Muhammad Fikri Nugraha, Daniel Alexander Changestu, Rizky Ramadhan, Tasya Salsabila, Arsila Nurizati, Sari Eka Pratiwi, Ysrafil Ysrafil

    Objectives: Current tuberculosis (TB) control strategies face limitations, such as low antibiotic treatment compliance and a rise in multidrug resistance. Furthermore, the lack of a safe and effective vaccine compounds these challenges. The limited efficacy of existing vaccines against TB underscores the urgency for innovative strategies, such as immunoinformatics. Consequently, this study aimed to design a targeted multi-epitope vaccine against TB infection utilizing an immunoinformatics approach.Methods: The multi-epitope vaccine targeted Ag85A, Ag85B, ESAT-6, and CFP-10 proteins. The design adopted various immunoinformatics tools for cytotoxic T lymphocyte (CTL), helper T lymphocyte (HTL), and linear B lymphocyte (LBL) epitope prediction, the assessment of vaccine characteristics, structure modeling, population coverage analysis, disulfide engineering, solubility prediction, molecular docking/dynamics with toll-like receptors (TLRs), codon optimization/cloning, and immune simulation.Results: The multi-epitope vaccine, which was assembled using 12 CTL, 25 HTL, and 21 LBL epitopes associated with CpG adjuvants, showed promising characteristics. The immunoinformatics analysis confirmed the antigenicity, immunogenicity, and lack of allergenicity. Physicochemical evaluations indicated that the proteins were stable, thermostable, hydrophilic, and highly soluble. Docking simulations suggested high-affinity binding to TLRs, including TLR2, TLR4, and TLR9. In silico immune simulation predicted strong T cell (cytokine release) and B cell (immunoglobulin release) responses.Conclusion: This immunoinformatics-designed multi-epitope vaccine targeting Ag85A, Ag85B, ESAT-6, and CFP-10 proteins showed promising characteristics in terms of stability, immunogenicity, antigenicity, solubility, and predicted induction of humoral and adaptive immune responses. This suggests its potential as a prophylactic and therapeutic vaccine against TB.


  • Open Access

    Chronotype, Eating Habits, and Body Mass Index in First-Year Undergraduate Medical Program Students

    by Daniel Alexander Changestu, Ery Hermawati, Agustina Arundina Triharja Tejoyuwono

    This cross-sectional study aimed to identify the correlation between chronotype and body mass index (BMI) in medical students, mediated by energy intake, and to explore eating habits. There were 46 participants who completed Morningness-Eveningness Questionnaire and Chrononutrition-Profile Questionnaire in the Indonesia version and a 3 days of 24-hour food record. Participants’ weight and height were measured by microtoise and digital body weight scale. Additionally, univariate and correlation analyses were conducted to identify the correlation of the variables. The study found no significant difference in the correlation between chronotype preference and BMI, chronotype preference and energy intake, and BMI and energy intake. Medical students had a habit of eating breakfast, even skipping breakfast, having dinner later, consuming the highest energy at lunchtime, and consuming high-calorie, high-fat, and high-sugar foods at night. The study revealed no significant correlation between chronotype, eating habits, and BMI. However, the eveningness medical students have bad eating habits.

  • Open Access

    POTENSI AKTIVITAS ANTIBAKTERI DAUN RAMBUSA (Passiflora foetida L.) SEBAGAI PENGOBATAN TRADISIONAL

    by Daniel Alexander Changestu, Syarifah Nurul Yanti Rizki Syahab Asseggaf, Muhammad Hafizuddin, Rohid Alfazon, Nazla Yuannefa, Al Munawar Kalahan

    Daun rambusa (Passiflora foetida L.) merupakan tanaman liar yang tersebar di berbagai daerah di Kalimantan Barat yang telah diteliti secara in vitro untuk mengidentifikasi aktivitas antibakteri dari kandungan ekstraknya. Oleh karena itu, perlu dilakukan telaah jurnal lebih lanjut mengenai aktivitas antimikroba dari ekstrak Passiflora foetida L. dari kandungan bioaktif pada ekstrak tanaman tersebut dan diharapkan dapat menjadi potensi baru dalam terapi infeksi bakteri bagi masyarakat umum yang sulit untuk menerima pengobatan konvensional. Pencarian artikel yang dilakukan dalam telaah naratif ini menggunakan mesin pencarian berupa Google Scholar, Garuda (Garba Rujukan Digital) dan PubMed. Pencarian dilakukan dengan memasukan kata kunci berdasarkan pola Medical Subject Headings (MeSH), yakni “Passiflora foetida L.” and (“Antimicrobial” or “Antibacterial”). Penelitian-penelitian menunjukkan bahwa kekuatan dari ekstrak daun Passiflora foetida L. dengan konsentrasi yang beragam memiliki potensi yang beragam juga terhadap spesies bakteri tertentu, mulai dari intermediate hingga resisten. Penelitian yang telah dilakukan menguji kekuatan aktivitas antibakteri terhadap bakteri Staphylococcus aureus, Staphylococcus epidermidis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Eschericia coli. Penelitian lain juga menunjukkan aktivitas dominan yang bekerja dalam penghambatan pertumbuhan bakteri antara lain alkaloid dan flavonoid. Daun rambusa memiliki potensi aktivitas antibakteri terhadap berbagai jenis bakteri dengan kandungan fitokimia yang berperan dalam proses penghambatan pertumbuhan bakteri ialah flavonoid dan alkaloid